316 related articles for article (PubMed ID: 24402710)
1. Immunopathogenesis of idiopathic nephrotic syndrome with relapse.
Sahali D; Sendeyo K; Mangier M; Audard V; Zhang SY; Lang P; Ollero M; Pawlak A
Semin Immunopathol; 2014 Jul; 36(4):421-9. PubMed ID: 24402710
[TBL] [Abstract][Full Text] [Related]
2. Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune Podocytopathies.
Ye Q; Zhou C; Wang D; Fu H; Wang J; Mao J
Clin Immunol; 2021 Nov; 232():108869. PubMed ID: 34600127
[TBL] [Abstract][Full Text] [Related]
3. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement.
Kim AH; Chung JJ; Akilesh S; Koziell A; Jain S; Hodgin JB; Miller MJ; Stappenbeck TS; Miner JH; Shaw AS
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093269
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome.
Jamin A; Dehoux L; Dossier C; Fila M; Heming N; Monteiro RC; Deschênes G
Clin Exp Immunol; 2015 Dec; 182(3):332-45. PubMed ID: 26123900
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis of idiopathic nephrotic syndrome.
Zhang SY; Audard V; Fan Q; Pawlak A; Lang P; Sahali D
Contrib Nephrol; 2011; 169():94-106. PubMed ID: 21252513
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against podocytic UCHL1 are associated with idiopathic nephrotic syndrome relapses and induce proteinuria in mice.
Jamin A; Berthelot L; Couderc A; Chemouny JM; Boedec E; Dehoux L; Abbad L; Dossier C; Daugas E; Monteiro RC; Deschênes G
J Autoimmun; 2018 May; 89():149-161. PubMed ID: 29307588
[TBL] [Abstract][Full Text] [Related]
7. T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome.
Guimarães FTL; Melo GEBA; Cordeiro TM; Feracin V; Vieira ER; Pereira WF; Pinheiro SVB; Miranda AS; Simões-E-Silva AC
J Pediatr (Rio J); 2018; 94(5):546-553. PubMed ID: 28963877
[TBL] [Abstract][Full Text] [Related]
8. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
9. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
10. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
11. B cell phenotype, activity, and function in idiopathic nephrotic syndrome.
Liu J; Guan F
Pediatr Res; 2023 Jun; 93(7):1828-1836. PubMed ID: 36316536
[TBL] [Abstract][Full Text] [Related]
12. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies.
Pereira Wde F; Brito-Melo GE; Guimarães FT; Carvalho TG; Mateo EC; Simões e Silva AC
Inflamm Res; 2014 Jan; 63(1):1-12. PubMed ID: 24121975
[TBL] [Abstract][Full Text] [Related]
13. Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes.
Nusshag C; Stütz A; Hägele S; Speer C; Kälble F; Eckert C; Brenner T; Weigand MA; Morath C; Reiser J; Zeier M; Krautkrämer E
Sci Rep; 2020 Nov; 10(1):19117. PubMed ID: 33154421
[TBL] [Abstract][Full Text] [Related]
14. Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men.
Ronco P; Debiec H
Semin Immunopathol; 2007 Nov; 29(4):445-58. PubMed ID: 17899086
[TBL] [Abstract][Full Text] [Related]
15. T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome.
Mansour H; Cheval L; Elalouf JM; Aude JC; Alyanakian MA; Mougenot B; Doucet A; Deschênes G
Kidney Int; 2005 Jun; 67(6):2168-77. PubMed ID: 15882260
[TBL] [Abstract][Full Text] [Related]
16. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases.
Wickman L; Afshinnia F; Wang SQ; Yang Y; Wang F; Chowdhury M; Graham D; Hawkins J; Nishizono R; Tanzer M; Wiggins J; Escobar GA; Rovin B; Song P; Gipson D; Kershaw D; Wiggins RC
J Am Soc Nephrol; 2013 Dec; 24(12):2081-95. PubMed ID: 24052633
[TBL] [Abstract][Full Text] [Related]
17. Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease.
Tian X; Ishibe S
Nephrol Dial Transplant; 2016 Oct; 31(10):1577-83. PubMed ID: 26968197
[TBL] [Abstract][Full Text] [Related]
18. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
19. The immunopathogenesis of idiopathic nephrotic syndrome: a narrative review of the literature.
Kitsou K; Askiti V; Mitsioni A; Spoulou V
Eur J Pediatr; 2022 Apr; 181(4):1395-1404. PubMed ID: 35098401
[TBL] [Abstract][Full Text] [Related]
20. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
